ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2025
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • 2020-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 2313

From Plaque to Plaque: Bridging Oral and Systemic Inflammation in Psoriasis and PsA

guru Vijay Chagalakondu, Vijaya prasanna Parimi and Pradeep S Anand, ESIC Medical College and Super Specilaity Hospital, hyderabad, Telangana, India

Meeting: ACR Convergence 2025

Keywords: Cutaneous, Psoriatic arthritis

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Tuesday, October 28, 2025

Title: (2305–2337) Spondyloarthritis Including Psoriatic Arthritis – Diagnosis, Manifestations, & Outcomes Poster III

Session Type: Poster Session C

Session Time: 10:30AM-12:30PM

Background/Purpose: Psoriasis and psoriatic arthritis (PsA) are two chronic inflammatory conditions which have similar immunopathological mechanisms which also cause periodontal disease. The association between these conditions is often under-recognized. This study aims to assess the prevalence and severity of periodontitis in psoriasis and psoriatic arthritis, evaluate its correlation with disease activity indices and identify the potential of oral health as a surrogate marker of systemic inflammation.

Methods: In this prospective triple-arm, case-control study, 120 participants were recruited into the study and were equally divided into three groups- healthy subjects as controls, patients with psoriasis and patients with PsA. A detailed periodontal examination was conducted which included measurement of Oral hygiene Index (OHI), gingival bleeding, probing depth (PD), clinical attachment loss (CAL) and missing teeth. Disease activity was measured using Psoriasis Area and Severity Index (PASI) for psoriasis, DAS28 and DAPSA for psoriatic arthritis. Statistical analysis was done using Kruskal Wallis and Spearman’s correlation coefficients and p value < 0.05 was considered as significant.

Results: Periodontitis was found to be more prevalent in PsA (89.7%) and psoriasis (87.8%) groups compared to healthy controls (32.5%) (p< 0.001). PsA group demonstrated severe periodontal disease activity with higher OHI, bleeding scores, PD and CAL (p < 0.05 for all). The correlation between indices of psoriasis and PsA with periodontal disease was positive. PASI correlated with bleeding (r=0.460), PD (r=0.338), and CAL (r=0.429), all p< 0.001.DAPSA correlated with bleeding (r=0.439, p< 0.001), PD (r=0.396, p=0.013), and CAL (r=0.358, p=0.025).DAS28 correlated with bleeding (r=0.438, p< 0.001), PD (r=0.325, p=0.043), and CRP (r=0.328, p=0.041) (Figure 2).

Conclusion: This study highlights the striking significant association between periodontal disease and disease activity of psoriasis. The study also highlights the fact that higher disease activity of periodontitis was observed in PsA group. Given the ease of periodontal assessment, it may serve as a non-invasive reflective biomarker of systemic inflammation in patients with PsA and psoriasis. The study also emphasizes the need for early periodontal screening in patients with psoriasis for timely identification and integrated approach of disease management (oral-systemic axis).

Supporting image 1

Supporting image 2


Disclosures: g. Chagalakondu: None; V. Parimi: None; P. Anand: None.

To cite this abstract in AMA style:

Chagalakondu g, Parimi V, Anand P. From Plaque to Plaque: Bridging Oral and Systemic Inflammation in Psoriasis and PsA [abstract]. Arthritis Rheumatol. 2025; 77 (suppl 9). https://acrabstracts.org/abstract/from-plaque-to-plaque-bridging-oral-and-systemic-inflammation-in-psoriasis-and-psa/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to ACR Convergence 2025

ACR Meeting Abstracts - https://acrabstracts.org/abstract/from-plaque-to-plaque-bridging-oral-and-systemic-inflammation-in-psoriasis-and-psa/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

Embargo Policy

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM CT on October 25. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology